Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancer
Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Theresia Thalhammer(Medical University of Vienna), Orsolya Német(Institute of Molecular Life Sciences), Majdah Sheikh(Medical University of Vienna), Angelika Reiner(Donauspital), Diana Mechtcheriakova(Comprehensive Cancer Center Vienna), Christoph Ausch(Ludwig Boltzmann Institute for Cardiovascular Research), Andreas Gleiß(Medical University of Vienna), Hajnalka Andrikovics(National Center for Epidemiology), Walter Jäger, Attila Tordai(Semmelweis University), Csilla Özvegy‐Laczka(Semmelweis University)
Cited by 8
Related Papers
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
|Blood Cancer Journal|2015|273